This study describes the conversion of murine PrP C by PrP Sc from three different mouse scrapie strains (ME7, 87V and 22A) and from a mouse-passaged bovine spongiform encephalopathy (BSE) strain (BSE/Bl6). This was demonstrated by a modified, non-radioactive, cell-free conversion assay using bacterial prion protein, which was converted into a proteinase K (PK ME7 and BSE prions led to unglycosylated, PK-digested, abnormal PrP res fragments, which differed in molecular mass by 1 kDa. Therefore, prion strain phenotypes were retained in the cell-free conversion, even when recombinant PrP C was used as the substrate. Moreover, co-incubation of ME7 and BSE prions resulted in equal amounts of both ME7-and BSE-derived PrP res fragments (as distinguished by their different molecular sizes) and also in a significantly increased total amount of de novo-generated PrP res . This was found to be more than twice the amount of either strain when incubated separately. This result indicates a synergistic effect of both strains during cell-free conversion. It is not yet known whether such a cooperative action between BSE and scrapie prions also occurs in vivo.
This study describes the conversion of murine PrP C by PrP Sc from three different mouse scrapie strains (ME7, 87V and 22A) and from a mouse-passaged bovine spongiform encephalopathy (BSE) strain (BSE/Bl6). This was demonstrated by a modified, non-radioactive, cell-free conversion assay using bacterial prion protein, which was converted into a proteinase K (PK)-resistant fragment designated PrP res . Using this assay, newly formed PrP res could be detected by an antibody that discriminated de novo PrP res and the original PrP Sc seed. The results suggested that PrP res formation occurs in three phases: the first 48 h when PrP res formation is delayed, followed by a period of substantially accelerated PrP res formation and a plateau phase when a maximum concentration of PrP res is reached after 72 h. The conversion of prokaryotically expressed PrP C by ME7 and BSE prions led to unglycosylated, PK-digested, abnormal PrP res fragments, which differed in molecular mass by 1 kDa. Therefore, prion strain phenotypes were retained in the cell-free conversion, even when recombinant PrP C was used as the substrate. Moreover, co-incubation of ME7 and BSE prions resulted in equal amounts of both ME7-and BSE-derived PrP res fragments (as distinguished by their different molecular sizes) and also in a significantly increased total amount of de novo-generated PrP res . This was found to be more than twice the amount of either strain when incubated separately. This result indicates a synergistic effect of both strains during cell-free conversion. It is not yet known whether such a cooperative action between BSE and scrapie prions also occurs in vivo.
INTRODUCTION
Prion diseases or transmissible spongiform encephalopathies (TSEs) are fatal neurodegenerative infectious diseases occurring in man and animals, which can be transmitted by natural or experimental pathways. During the development of the disease, normal protease-sensitive prion protein (PrP C ) is converted into an abnormal protease-resistant isoform, designated PrP
Sc . This transition is probably induced by a profound alteration in the secondary and tertiary structure of PrP . It also appears to be a fundamental process in the propagation of the causative agent and in the pathogenesis of TSEs. This conformational rearrangement correlates with the acquisition of a partial proteinase K (PK) resistance of the prion protein.
Two models explaining the conversion of PrP C into PrP Sc have been proposed (reviewed by Aguzzi & Polymenidou, 2004 ). The first is referred to as template-directed refolding in which the formation of a heterodimer between endogenous PrP C and exogenous PrP Sc induces the transformation of PrP C into PrP Sc . Conversion of PrP C itself into PrP Sc is inhibited by a high-energy barrier. A second model, called seeded nucleation, suggests that both monomeric forms -PrP C and PrP Sc -are in an equilibrium. After the formation of monomeric PrP Sc into multimeric 'infectious' seeds, PrP C is converted and incorporated into the growing fibrillar amyloid aggregates.
A major problem with the 'protein-only' hypothesis (Prusiner, 1984) of prion propagation is the explanation of the existence of multiple, phenotypically distinct prion isolates or strains. These different strains show distinct incubation times and specific patterns of neuropathological targeting in the brain. Prion strains may also differ in their biochemical properties such as glycoform ratios (Kascsak et al., 1986) , aggregation state and PK digestion patterns of PrP Sc (Kuczius & Groschup, 1999) . As the amino acid sequence of the prion protein is identical in different prion strains within the same species, it is considered that the conformation and/or post-translational modifications of PrP Sc carry the information that defines these strains. For instance, there are two strains of hamster-adapted transmissible mink encephalopathy (TME) called Hyper (HY) and Drowsy (DY) (Bessen & Marsh, 1992) . Treatment of PrP Sc of these two strains with PK results in fragments of different sizes. These differently sized fragments could also be transmitted to newly formed PrP Sc /PrP res in vivo and in vitro (Bartz et al., 2000) . However, the molecular mechanism of this strain specificity remains unclear.
Although most investigations have been carried out in vivo in the form of infection studies, suitable in vitro systems have recently been established that permit the biological characteristics of TSEs to be studied. Neuronal cells (ScN2A, SMB) that are persistently infected with mouse-passaged scrapie strains are commonly used to analyse prion conversion in vitro. These cells are able to convert endogenous PrP C into PrP Sc and accumulate PrP Sc over several passages (Race et al., 1987; Butler et al., 1988) .
In contrast to infection studies in animals or with scrapieinfected cultured tissue cells, cell-free conversion assays utilize purified PrP C and PrP Sc , where PrP C is converted into its protease-resistant form, PrP res , with characteristics similar to those of the progenitor PrP Sc (Kocisko et al., 1994) . In previously published cell-free conversion studies, radiolabelled PrP C was used as substrate and PrP res formation was visualized by phosphorimaging autoradiography (Caughey et al., 1999a) . Cell-free conversion assays represent a precise system to analyse molecular factors as well as the kinetics of conversion reactions (Bossers et al., 2003) . The system has been used for the analysis of species and strain specificities of the prion protein, e.g. the interaction of mouse and hamster PrP C with mouse-and hamster-derived PrP Sc (Kocisko et al., 1995) , of human PrP C with bovine spongiform encephalopathy (BSE) and scrapie (Raymond et al., 1997) and of several PrP C species with chronic wasting disease (Raymond et al., 2000) . Additionally, the interaction of ovine PrP C variants with different scrapie strains (Bossers et al., 1996 and of hamster PrP C with TME strains (Bessen et al., 1995) has been examined.
Protein misfolding cyclic amplification is another cell-free conversion system, in which the seeding effect of PrP Sc is enhanced by serial ultrasonification to repetitively generate conversion-active fibrils (Saborio et al., 2001) . Recently, it has been reported that PrP res generated by this method is infectious (Castilla et al., 2005) .
In another cell-free system, recombinant PrP C was turned into PK-resistant fibrillar aggregates, even without the addition of PrP Sc , when suitable denaturants and buffer conditions were used (Bocharova et al., 2005; Baskakov & Bocharova, 2005 ).
The present study was performed to characterize both the conversion kinetics of bacterial prion protein and the interaction of BSE and scrapie strains in a modified, cell-free assay. De novo-formed PrP res was detected using a specific antibody that discriminated between PrP res and the PrP Sc seed.
METHODS
Prokaryotic expression of recombinant PrP
The open reading frame of L42-tagged mouse prion gene (s7 Sinc allele), which encodes aa 23-231, was PCR amplified using primers mp1 (59-CCCTCGAGAAAAAGCGGCCAAAGCC-39) and mp2 (59-CCGGA-TCCCTAGCTGGATCTTCTCCCG-39) from a template encoding mouse PrP in which tryptophan at position 144 was substituted by tyrosine (Vorberg et al., 2000) . This construct was cloned into the Escherichia coli expression vector pET19b (Novagen) using the XhoI and BamHI cleavage sites. Due to the vector composition, this construct contained an N-terminal histidine (His) tag and an additional enterokinase cleavage site. The construct was expressed in Origami (DE3) cells (Novagen). Purification was performed under denaturing conditions according to the manufacturer's instructions (Qiagen): cells of a 50 ml E. coli culture were harvested with lysis buffer (8 M urea, 0?1 M NaH 2 PO 4 , 0?01 M Tris, adjusted to pH 8?0 with NaOH) and gently shaken for 1 h. Samples were centrifuged at 14 000 r. In order to obtain the high yields of pure protein needed for circular dichroism (CD) spectroscopy, PrP C was purified according to a protocol described previously (Zahn et al., 1997) . For cell-free conversion studies, this PrP C preparation was diluted to a final concentration of 20 mg ml 21 in 20 mM HEPES/KOH (pH 7?4). Fulllength recombinant hamster PrP C was purchased from Prionics AG.
CD spectra were recorded on a Jasco J810 spectropolarimeter using a cuvette with a 2 mm path length. Measurements were carried out at 20 uC in H 2 O at a final protein concentration of 100 mg ml
21
.
Propagation of BSE and scrapie strains. C57BL/6 mice were inoculated intracerebrally with 20 ml 1 % mouse brain homogenate using mouse scrapie strains ME7, 22A and RML and with a BSE strain. The BSE strain was initially isolated from a German BSE case using C57BL/6 mice and was repeatedly subpassaged thereafter. The scrapie strain 87V was propagated in VM mice (kindly provided by Dr M. Bruce, Institute for Animal Health, Edinburgh, UK) and the hamster scrapie strain 263K was propagated in Syrian golden hamsters. After the onset of clinical symptoms, animals were euthanized and their brains were removed and stored at 220 uC.
Purification of PrP

Sc
. Purification was performed according to an established procedure (Caughey et al., 1999b) with some modifications. Mouse scrapie brain (1 g) was homogenized on ice in 15 ml TEND buffer [10 mM Tris/HCl (pH 8?3), 1 mM EDTA, 130 mM NaCl, 1 mM DTT] containing 10 % N-lauroyl sarcosine with protease inhibitors (0?1 mM Pefabloc, 0?5 mg leupeptin ml 21 , 1?0 mg aprotinin ml 21 , 0?7 mg pepstatin ml 21 ) and then centrifuged at 23 000 r.p.m. in a TLA 100.4 rotor (Beckman) for 30 min (4 uC).
The supernatant was then recentrifuged for 2?5 h at 58 000 r.p.m. (TLA 100.4 rotor, 4 uC). The resulting pellet was resuspended in 15 ml TEND buffer containing 10 % NaCl and 1 % sulfobetaine 14 (SB14). This suspension was then centrifuged at 68 000 r.p.m. for 1?5 h (TLA 100.4 rotor, 20 uC). The remaining pellet was resuspended in TMS buffer (10 mM Tris/HCl, pH 7?4, 5 mM MgCl 2 , 0?1 M NaCl) containing 10 % (w/v) NaCl and 1 % (w/v) SB14 and carefully loaded on to a sucrose cushion consisting of 1?0 M sucrose, 0?1 M NaCl and 0?5 % SB14 for a final centrifugation at 68 000 r.p.m. for 1?5 h (TLA 100.4 rotor, 20 uC). The pellet was collected in PBS containing 0?5 % SB14, sonicated and homogenized in a Teflon glass dounce homogenizer. Aliquots were stored at 220 uC.
Each conversion reaction was carried out with approximately 400-800 ng PrP Sc material. As the exact concentration was impossible to measure due to the fibrillar properties of PrP Sc , quantification was estimated on the basis of immunoblot signal intensities.
PrP conversion assay. For the conversion reaction, 400 ng bacterial prion protein PrP C was incubated with 400-800 ng PrP Sc in a conversion buffer consisting of 50 mM citrate/NaOH (pH 6?0), 200 mM KCl, 5 mM MgCl 2 and 1?25 % Sarkosyl (Horiuchi et al., 2000) . A standard incubation was carried out for 3 days at 37 uC. Three controls were used: (i) PrP C without PrP Sc or PK, (ii) PrP C without PrP Sc , incubated with PK, and (iii) PrP C incubated together with PrP Sc . The third control was immediately frozen (t=0). After the end of the incubation, the samples were treated with PK at a final concentration of 30 mg ml 21 (in 50 mM Tris/HCl, pH 7?4, 150 mM NaCl in 50 ml) and incubated for 1 h at 37 uC. The reaction was stopped with 10 mM PMSF and 20 mg of a carrier protein (thyroglobulin) was added. Samples were then incubated with 4 vols of methanol at 220 uC. The precipitated proteins were pelleted by centrifugation at 14 000 r.p.m. in an FA-45-30-11 rotor (Eppendorf) for 15 min.
SDS-PAGE and immunoblotting. Pellets were resuspended in a loading buffer containing 1 % (w/v) SDS, 25 mM Tris/HCl (pH 7?4), 0?5 % mercaptoethanol and 0?001 % bromophenol blue, heat-denatured for 5 min at 95 uC and loaded on to SDS-polyacrylamide gels containing 16 % bisacrylamide acrylamide/bisacrylamide (37?5 : 1). After electrophoresis, proteins were transferred to a PVDF membrane in a semi-dry chamber. Membranes were incubated in blocking buffer (PBS containing 0?1 % Tween 20 and 5 % non-fat dried milk powder), followed by incubation for 60 min with monoclonal antibody (mAb) L42 (Harmeyer et al., 1998) or polyclonal antibody (pAb) Ra10 (Groschup et al., 1997) . Ra10 was generated against a 16mer peptide based on the ovine sequence (aa 107-122) (Groschup et al., 1994) . Membranes were washed three times for 10 min each with PBS containing 0?1 % Tween 20 and incubated for 60 min with a secondary antibody conjugated to alkaline phosphatase (AP) (goat anti-mouse-AP or goat anti-rabbit-AP). Membranes were washed again three times for 10 min each with PBS containing 0?1 % Tween 20. Subsequently, the chemiluminescence substrate CDP Star (Tropix) was applied and incubated on the membrane for 5 min before the light signals were detected directly using a camera. For stripping, the membranes were incubated twice for 15 min each with a buffer containing 0?2 M glycine/HCl (pH 2?0) and 1 % SDS.
Visualization was achieved using the Bio-Rad VersaDoc imaging system and quantification was measured using Quantity One quantification software (Bio-Rad). Conversion rate was estimated as the ratio of PrP res (PK-digested) to PrP C (undigested control). The relative conversion efficiency (%) was calculated as follows: (signal volume of PrP res digested with PK)/(signal volume of PrP C before PK digestion)6100. The conversion rate of each time point was calculated as a mean value from three independent reactions. Molecular masses were determined using a molecular mass marker (FLI marker, developed at the Friedrich-Loeffler-Institut), which was a protein ladder with 1 kDa incremental steps (from 16 to 23 kDa). Each of these proteins harboured an N-terminal 6-His tag (Groschup et al., 2001) , which was detected using an anti-His antibody (RGS-His; Qiagen).
RESULTS
A cell-free conversion system for recombinant PrP C was used to study strain-specific effects on the prion conversion reaction. For this purpose, PrP Sc was obtained from four different mouse-passaged scrapie strains, one mousepassaged BSE strain and one hamster-passaged scrapie strain. In contrast to most previous studies, prokaryotic L42 epitope-tagged PrP C (see Methods) was utilized as a conversion substrate that could be visualized selectively on immunoblots by using the highly specific mAb L42 and through a sensitive chemiluminescence detection system. Therefore, no radioactive PrP C labelling was needed. Moreover, PrP C carried a His tag at the N terminus to allow purification of the protein. PrP
Sc and PrP C were added at approximately equimolar amounts as estimated by comparative immunoblotting and the conversion reaction was carried out under non-denaturing, semi-native conditions.
In the first experiments, PrP C was incubated for 3 days with PrP Sc from scrapie strain ME7. After PK digestion and Western blotting, a PK-resistant PrP res fragment with a molecular mass of 17 kDa could be detected by mAb L42 (Fig. 1, lanes 4-5) . Two controls were carried out: PrP C without PrP Sc (Fig. 1, lane 2) and PrP C incubated with PrP Sc that was stopped immediately after incubation (Fig. 1, lane  3) . The L42-tagged PrP res fragment was partially PK resistant, i.e. had a 9 kDa lower molecular mass than the undigested precursor, which resulted from the removal of the N terminus (Fig. 1, lane 1) . The conversion rate (% PrP res compared with the undigested PrP C control) was approximately 1 % (as determined by photoimaging).
Recombinant L42-tagged PrP C , purified according to the method of Zahn et al. (1997) , exhibited CD spectra similar to unmodified recombinant hamster PrP C (Fig. 2a) and human PrP C (Zahn et al., 1997) , which were indicative of an authentic secondary structure and protein folding. Proteins obtained from both purification methods were converted with the same conversion rate and PrP res fragments showed biochemical characteristics similar to the PK-resistant PrP res fragments (Fig. 2b) . All subsequent reactions were carried out with the recombinant prion protein purified according to the Qiagen protocol (see Methods).
In a next set of experiments, PrP C was incubated for 3 days with scrapie ME7 or BSE PrP Sc . These two strains can be distinguished biochemically by the PK cleavage site of the corresponding PrP Sc , i.e. after PK treatment, the molecular mass of unglycosylated BSE PrP Sc is 1-2 kDa lower than that of scrapie ME7 PrP Sc (Fig. 3 ) (Kuczius & Groschup, 1999; Hayashi et al., 2005) . This molecular size difference observed in eukaryotic PrP Sc was also apparent in the cell-freeconverted prokaryotic PrP res fragments (Fig. 4) . PrP res fragments derived from the BSE strain (Fig. 4a , lanes 7-8) exhibited a molecular mass that was 1 kDa lower than the ME7-derived PrP res fragments (Fig. 4a, lanes 5-6) . The cellfree conversion of PrP C with BSE PrP Sc also produced two additional fragments at approximately 14 and 15 kDa (Fig. 4a, lanes 7-8) . These additional fragments corresponded to the C terminus and may have resulted from incompletely converted and hence further truncated PrP res . Similar low-molecular-mass fragments have been reported for cell-free-converted eukaryotic PrP res (Horiuchi et al., 2000) . To visualize the PrP Sc seed, the same blot was stripped and reincubated with pAb Ra10, which detects wild-type mouse PrP Sc in strain ME7 and in BSE as unglycosylated, monoglycosylated and diglycosylated bands (Fig. 4b, lanes 3-8) . Again, the differences in molecular size between the two strains were observed (Fig. 4b, compare  lanes 3 and 4) . In contrast to mAb L42 (Fig. 4a, lane 1) , pAb Ra10 had a significantly lower affinity to L42-tagged PrP C (Fig. 4b, lane 1) . For this reason, no PrP res fragments were visualized by pAb Ra10.
The same conversion technique was used with other scrapie strains (22A, 87V, RML and 263K). In order to analyse the temporal kinetics of the cell-free conversion reaction, all PrP Sc strains were incubated with PrP C for various lengths of time (24, 48, 72 and 168 h) (Fig. 5a ). For unknown reasons, the mouse scrapie strain RML converted PrP C very inefficiently, if at all. The hamster scrapie strain 263K was used as another control and also did not convert murine PrP C , due to the existing species barrier (data not shown).
The respective conversion rates were quantified (Table 1) and are depicted in Fig. 5(a) . For each graph, three independent conversion reactions were carried out. After an initial lag phase, which lasted up to 48 h, there was an elevated conversion activity, so that the PrP res signals peaked at 72 h. No further increase was seen and a steady state was reached, which lasted until approximately 168 h. The peak values for the newly converted prion proteins ranged from around 1 % in strains ME7 and BSE to 2 % in the 22A strain. Intermediate values were seen in strain 87V.
The above kinetic studies were carried out using PrP res from a given source. In the following investigations, PrP C was coincubated with strains ME7 and the BSE strain (400 ng each) to study potential inhibitory or synergistic effects over time (Fig. 6 ). This co-incubation produced a PrP res doublet band, having two distinct fragments with a size difference of 1 kDa (Fig. 6 , lanes 5-6). This result indicated that both conversion reactions were equally successful and without any intrinsic inhibitory effects. Due to the different molecular masses of the PrP res fragments (17 kDa derived from ME7 compared with 16 kDa derived from BSE), the quantification of the corresponding fragments was possible, even in co-incubation studies. Interestingly, co-incubation of ME7 and BSE PrP Sc led to significantly higher amounts of ME7-derived and BSE-derived PrP res fragments compared with the amounts derived by each in single conversion reactions (Fig. 6 , lanes 1-4 compared with lanes 5 and 6). Quantification and the temporal kinetics of the coincubation are summarized in Table 2 and illustrated in Fig. 5(b) . This strong increase in the level of PrP res fragments occurred during the enhancement phase after 48 h. It was at this point that ME7-derived conversion products reached their peak conversion rate of 2?7 %, whereas the BSE-derived PrP res fragments reached their peak conversion rate of 2?6 % after 72 h. These results indicated an approximately twice as high conversion rate for the combined BSE and ME7 reactions, with a fourfold higher overall value compared with single conversion reactions. This indicated a substantial additional interaction between these two prion strains. This result was not simply an additive effect of the total of 800 ng PrP Sc : the amount of individual ME7 and BSE material remained constant compared with the single incubation (400 ng), but the amount of both PrP res fragments, which could be quantified independently, increased significantly during coincubation.
In additional experiments, co-incubation of ME7 or BSE with RML scrapie prions was carried out (Table 2 and Fig. 5b ). PrP Sc derived from the scrapie strain RML displayed no detectable cell-free conversion activity (Table 1) , and this was also seen during simultaneous incubation (Table 2 and Fig. 5b) : maximum conversion values were 0?53 (for ME7) and 0?98 (for BSE). In accordance with these results, co-incubation with RML prions did not display the synergistic effects that were observed in the co-incubation of scrapie ME7 and BSE prions.
DISCUSSION
A cell-free conversion assay was established, where bacterial PrP C was converted into a PK-resistant isoform (PrP res ) using mouse-derived PrP Sc . PrP res exhibits the same biochemical properties, e.g. partial resistance to PK, as its pathological PrP Sc isoform. The PrP C used in this study was modified by exchange of a tryptophan for a tyrosine at position 144, which created an epitope for mAb L42 and made it distinguishable from murine PrP Sc . In this study, recombinant PrP C was also modified by the N-terminal attachment of 14 aa and of a His tag. It has been shown previously that N-terminal tagging of PrP C has no effect on PrP processing (Gauczynski et al., 2002) and does not interfere with its conversion into PrP Sc (Telling et al., 1997) . Moreover, prion protein fused at its N terminus to green fluorescent protein supports prion replication in transgenic mice (Bian et al., 2006) . We also showed by CD spectroscopy that the additional and/or mutated residues (L42 epitope, His tag and enterokinase cleavage site) of L42-tagged PrP C had no significant effect on the secondary structure (Fig. 2a) .
Based on the immunoblotting data, approximately 1-3 % of the recombinant PrP C was converted into PrP res using this cell-free conversion assay when PrP Sc was added at equimolar concentrations. This efficiency was ten times lower than in previous reports using cell-free conversion with radiolabelled PrP C (Bossers et al., 1997; Caughey et al., 1999b; Kirby et al., 2003) . Hence, it cannot be excluded that 1 and 2) or the BSE strain (lanes 3 and 4), as well as by co-incubation with the ME7 and BSE strains (lanes 5 and 6). PrP res was detected using mAb L42. the L42 epitope is disproportionally less accessible in the denatured PrP res fragment than in PrP C . However, the signal intensities were in the linear range of the Versadoc quantification system and permitted an exact and specific data analysis.
The cell-free conversion assay was carried out with six different scrapie strains/isolates. Four mouse strains (ME7, 87V, 22A and BSE) converted the recombinant mouse prion protein, mimicking the situation in vivo. A clear species specificity was observed, as the hamster scrapie strain 263K did not convert mouse PrP C in the cell-free assay. This is in accordance with a previously published report (Kirby et al., 2003) and reflects the inefficient experimental transmissibility of scrapie strain 263K to mice. However, a rather low efficiency, if any, was also found for the mouse scrapie strain RML, although most in vivo transmission characteristics of RML are similar to those of the other four mouse scrapie strains. Unusual behaviour with the RML strain during conversion in vitro has been described previously (Vorberg & Priola (2002) . Indeed, biochemical differences are seen in PrP Sc glycosylation: RML-derived PrP Sc consists of a higher proportion of monoglycosylated protein compared with that derived from strains ME7, 87V, 22A and from BSE (Groschup & Kuczius, 2002) , which may contribute to the failure to convert the bacterial prion protein by strain RML.
According to the data presented here, the kinetic stages involving the conversion of PrP C into PrP res using the three scrapie (ME7, 87V and 22A) strains and the BSE strain can be subdivided into three phases: an initial lag phase, followed by an efficient amplification phase and finally a plateau phase. These three stages can be explained by modified seeded nucleation reactions. Initially, PrP Sc fibrils are broken into aggregates by the sonic treatment. However, they seem to require further maturation before efficient conversion can take place. It remains to be established whether conversion-active seeds are generated by further dissociation or by regeneration of the existing fragments. This is in accordance with a recent investigation (Silveira et al., 2005) in which particles consisting of 14-28 PrP Sc molecules were identified to be the most efficient initiators of TSE disease. A second explanation for this initial delay may be the low binding efficiency of recombinant PrP C to PrP Sc , which retards the conversion rate considerably in the first 48 h. However, the conversion of recombinant PrP C increases when sufficient amounts of de novo-formed PrP res are generated, which may function more efficiently as the progenitor seed. An equilibrium may eventually be reached between inactive PrP Sc multimers and conversion-active seeds, resulting in the PrP res plateau phase.
These observations differ from previously reported conversion kinetics (Chabry et al., 1999) . These authors observed no initial delay and the de novo PrP res levels had already peaked after 36 h and remained stable for up to 80 h. However, in previous studies, the PrP Sc used was pretreated with 2?5 M guanidine hydrochloride. In another study (Mulcahy & Bessen, 2004) , the authors applied milder denaturation conditions (1?0 M guanidine hydrochloride) for PrP Sc and reported an elongation phase that continued up to 72-96 h. A significant increase in the conversion rate was observed after 48 h, which is similar to the data presented in this study. A steady state was reached after 120 h (compared with 72 h in this study) and was preceded by a depolymerization phase. The lack of a depolymerization phase in our study is in accordance with data from a previous study (Callahan et al., 2001) in which PrP aggregation was not reversible in the absence of guanidine hydrochloride.
Our study shows that PrP Sc derived from two strains (ME7 and BSE) can convert the same unglycosylated PrP C precursor into two different PrP res fragments. Moreover, the newly formed fragments retained the same difference in molecular size of approximately 1 kDa in comparison with the PK-digested and unglycosylated PrP Sc fragments. These results show that scrapie and BSE strains can transmit their own biochemical properties, even to unglycosylated bacterial PrP C . Both strains converted the prion protein at equal efficiencies of about 1 %. The formation of strains is attributed to different conformations of PrP Sc , which lead to different PK cleavage sites. Similar results were achieved in a previous study where two distinct hamster strains, HY and DY, were able to transmit their conformation to eukaryotic PrP C (Bessen et al., 1995) . In these studies, however, PrP Sc was partly denatured by chaotropic salts (guanidine hydrochloride).
In a co-incubation study, where scrapie strain ME7 and BSE were incubated simultaneously with PrP C , PrP res fragments generated from ME7 as well as from BSE were detectable after 72 h. Due to their size difference of 1 kDa, both PrP res fragments could be quantified independently. Newly formed PrP res levels in the co-incubation experiment were significantly higher than in separate ME7 or BSE seed-driven reactions.
This phenomenon indicates that these prion strains not only retain their ability to convert PrP C under such conditions, but may even cooperate in the generation of PrP res . One explanation according to the modified seeded nucleation model is that after sonication the dissolved PrP Sc monomers reassociate into oligomeric or multimeric seeds that are composed of both ME7 and BSE PrP Sc molecules. These aggregates may then function as accessory initiation sites for the conversion of bacterial PrP C .
Co-incubation of the scrapie ME7 or the BSE strain with the RML strain showed no cooperative effects on the conversion reaction. As before, RML PrP Sc lacked an intrinsic conversion activity, which was demonstrated during the co-incubation. In fact, it appeared to show a moderate inhibitory effect on PrP res generation by ME7 or BSE PrP Sc .
This is the first time that a cooperative interaction between two prion strains has been shown in a cell-free conversion assay. Further experiments will focus on longer incubation times (>168 h) to reveal possible selection and competition effects between strains. Such effects have been described in experiments in vivo. For example, a blocking effect of the long-incubation-period scrapie strain 22A on its shortincubation-period counterpart 22C has already been reported (Kimberlin & Walker, 1985) . Indeed, when strain 22A was inoculated 100 days prior to strain 22C, both incubation time and neuropathology were characteristic of the 22A strain. This strain selection, however, did not depend only on the incubation times, i.e. the kinetics of the PrP replication, but also on the challenge doses. Bartz et al. (2000) used a long-incubation-period (DY) and a shortincubation-period (HY) TME strain to examine the selection process. Using comparable infectious doses, the HY strain dominated the DY strain after several passages in a new host species. However, high doses of the DY strain also inhibited formation of the HY phenotype. Similarly, Baron & Bicabe (2001) showed that simultaneous inoculation of BSE and scrapie prions into mice resulted in the selection mainly of the scrapie isolate, which induced a characteristic PrP Sc formation and neuropathology.
Our results were observed when using purified PrP Sc seeds and recombinant PrP C as a substrate. The results suggest that the strain specificities and synergisms/antagonisms observed in vivo may at least partly be encoded by the intrinsic properties of PrP Sc . Our data therefore underline the importance of cellular and abnormal prion proteins on the efficiency and quality of PrP conversion.
